Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience.
Leuk Res. 2024 Jan;136:107421. doi: 10.1016/j.leukres.2023.107421. Epub 2023 Nov 18.
Leuk Res. 2024.
PMID: 38042648
No abstract available.
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.
Boscaro E, Urbino I, Catania FM, Arrigo G, Secreto C, Olivi M, D'Ardia S, Frairia C, Giai V, Freilone R, Ferrero D, Audisio E, Cerrano M.
Boscaro E, et al. Among authors: catania fm.
Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512.
Cancers (Basel). 2023.
PMID: 37444622
Free PMC article.
Review.
Item in Clipboard
Cite
Cite